#ProstateCancer

Prostate cancer, the second most commonly diagnosed cancer among men worldwide, is again in the headlines as global cases continue to rise and new research underscores the urgent need for preventive measures. Recent estimates from the National Cancer Institute forecast more than 300,000 new cases in 2025 alone, marking prostate cancer as an escalating public health challenge not only globally but for Thailand’s aging male population. As medical experts intensify calls for awareness and regular screenings, cutting-edge studies are shining a light on modifiable lifestyle factors that may help stem the tide of this disease.

Recent news of former US President Joseph Biden’s advanced prostate cancer has reignited global debate, including among Thai health professionals and men, about the value of prostate-specific antigen (PSA) blood tests for the early detection of prostate cancer. Prostate cancer, the most commonly diagnosed cancer among men in the United States and an important concern worldwide, presents a unique challenge: distinguishing aggressive, potentially deadly tumors from slow-growing ones that may never pose harm. This ongoing health debate holds particular significance for Thai men, as prostate cancer incidence in Thailand has gradually risen—mirroring trends in the West as life expectancy increases and populations age. Understanding the evolving research on PSA testing can help Thai families make informed decisions about their own health.

Prostate cancer has once again captured global attention following the recent diagnosis of former US President Joe Biden, shining a spotlight on a disease that is the most common cancer among men worldwide. While headlines often tout new prevention measures or promising lifestyle tweaks, leading experts have clarified that the factors most responsible for a man’s risk of developing prostate cancer lie largely beyond individual control: age, ethnicity, and family history. This evidence-based perspective, backed by the latest research, has vital implications for men in Thailand, where rising cancer rates are signaling the need for smarter screening and public health strategies.

Recent renewed attention to prostate cancer and the PSA screening test, spurred by the diagnosis of former US President Joseph Biden, is once again igniting debate among health experts and patients worldwide — including in Thailand. Prostate cancer remains the most commonly diagnosed cancer among men in the United States and is a significant health concern for aging populations globally. The latest research and guidance show that the path forward for PSA (prostate-specific antigen) testing is both complicated and deeply personal, underscoring an urgent need for Thai men and their healthcare practitioners to weigh the pros and cons of screening within the context of current science and local realities.

A surge in recent research has clarified the true drivers behind prostate cancer risk, providing both reassurance and actionable information for millions of men in Thailand and around the globe. Spurred by high-profile diagnoses and persistent myths, these new scientific findings help separate established facts from common misconceptions about this frequently diagnosed but often misunderstood cancer.

Prostate cancer is one of the most prevalent cancers among men worldwide, including in Thailand, where an ageing population and changing lifestyles have brought greater attention to men’s health issues. Although conversations about prostate cancer often focus on concerns after publicized diagnoses of well-known figures, a clearer understanding of genuine risk factors is vital for early detection and prevention. According to recent umbrella reviews of scientific literature, long-standing risk factors such as advancing age, ethnicity, and family history remain central, but new genetic insights and lifestyle considerations are also emerging as important elements shaping an individual’s risk profile (PubMed Review; PMC Article).